Market OpportunityBroader GLP-1 adoption is expected to catalyze new demand for skin tightening treatments, positioning Apyx as one of the best companies to capitalize on this growing market.
Product DevelopmentApyx Medical announced it submitted a 510(k) for AYON, an all-in-one body contouring platform, ahead of schedule.
Technological AdvantageRenuvion is a unique, minimally invasive skin tightening platform backed by robust clinical data, which enables faster treatment times, greater soft tissue contraction and fewer adverse events.